tendinopathy
-
Hospitals
CollPlant Receives CE Mark for Vergenix™STR for Treatment of Tendinopathy
NESS ZIONA, Israel, October 19, 2016 /PRNewswire/ — CollPlant (TASE: CLPT), a regenerative medicine company utilizing its proprietary plant-based rhCollagen (recombinant human collagen) technology…
Read More » -
Recon
CollPlant Reports Positive Interim Trial Results for Vergenix™STR, Indicated for the Treatment of Tendinopathy
CollPlant Ltd. (TASE:CLPT), a regenerative medicine company utilizing its proprietary plant-based rhCollagen technology for tissue repair products, today announced positive…
Read More » -
Biologics
CollPlant Reports Positive Interim Trial Results
CollPlant Ltd. (TASE:CLPT; OTC:CQPTY), a regenerative medicine company utilizing its proprietary plant-based rhCollagen technology for tissue repair products, today announced…
Read More »